StockData
Lifecore Biomedical, Inc. logo

Lifecore Biomedical, Inc. (LFCR) stock

LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
Số liệu tài chính tới Q4 năm tài chính 2025, quý kết thúc ngày May 25, 2025Last filing: 10-Q on Nov 4, 2026Score 4/30
$6.39−0.03 (-0.39%)

Close on Nov 17, 2026Market cap $241.88MP/E –Yield –

Lifecore Biomedical enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Lifecore Biomedical's enterprise value was $224.99M on Nov 11, 2026, against $278.08M a year earlier. Over the last 5 years it ranged from $121.47M to $464.97M, with a median of $288.53M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$224.99M-22.0%
2025Dec 31, 2025$288.57M-12.7%
2024Dec 31, 2024$330.37M+22.9%
2023Dec 29, 2023$268.71M-6.1%
2022Dec 30, 2022$286.11M-36.4%
2021Dec 31, 2021$449.92M+6.7%
2020Dec 31, 2020$421.78M-0.1%
2019Dec 31, 2019$422.19M+14.6%
2018Dec 31, 2018$368.25M-4.6%
2017Dec 29, 2017$385.94M-8.3%
2016Dec 30, 2016$420.95M+18.6%
2015Dec 31, 2015$354.80M-12.2%
2014Dec 31, 2014$404.00M+15.0%
2013Dec 31, 2013$351.43M+24.8%
2012Dec 31, 2012$281.56M+121.6%
2011Dec 30, 2011$127.08M–
2010Dec 31, 2010-$27.66M–

More Lifecore Biomedical figures

See a number that looks wrong?